These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 23481164)

  • 21. Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.
    Greer MD; Shih JH; Lay N; Barrett T; Kayat Bittencourt L; Borofsky S; Kabakus IM; Law YM; Marko J; Shebel H; Mertan FV; Merino MJ; Wood BJ; Pinto PA; Summers RM; Choyke PL; Turkbey B
    Radiology; 2017 Dec; 285(3):859-869. PubMed ID: 28727501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.
    Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B
    Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
    PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?
    Alonzo F; Melodelima C; Bratan F; Vitry T; Crouzet S; Gelet A; Rouvière O
    Diagn Interv Imaging; 2016 Apr; 97(4):433-41. PubMed ID: 26928245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Beddy P; Moyle P; Kataoka M; Yamamoto AK; Joubert I; Lomas D; Crawford R; Sala E
    Radiology; 2012 Feb; 262(2):530-7. PubMed ID: 22114239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
    Ei Khouli RH; Jacobs MA; Mezban SD; Huang P; Kamel IR; Macura KJ; Bluemke DA
    Radiology; 2010 Jul; 256(1):64-73. PubMed ID: 20574085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications.
    Vargas HA; Akin O; Franiel T; Goldman DA; Udo K; Touijer KA; Reuter VE; Hricak H
    Radiology; 2012 Mar; 262(3):894-902. PubMed ID: 22357889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
    Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
    Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR-guided prostate biopsy for planning of focal salvage after radiation therapy.
    Ménard C; Iupati D; Publicover J; Lee J; Abed J; O'Leary G; Simeonov A; Foltz WD; Milosevic M; Catton C; Morton G; Bristow R; Bayley A; Atenafu EG; Evans AJ; Jaffray DA; Chung P; Brock KK; Haider MA
    Radiology; 2015 Jan; 274(1):181-91. PubMed ID: 25203127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T.
    Lin G; Huang YT; Chao A; Lin YC; Yang LY; Wu RC; Lu HY; Ng SH; Ng KK; Lai CH
    Eur Radiol; 2017 May; 27(5):1867-1876. PubMed ID: 27631107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.
    Turkbey B; Pinto PA; Mani H; Bernardo M; Pang Y; McKinney YL; Khurana K; Ravizzini GC; Albert PS; Merino MJ; Choyke PL
    Radiology; 2010 Apr; 255(1):89-99. PubMed ID: 20308447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.
    Barth BK; De Visschere PJL; Cornelius A; Nicolau C; Vargas HA; Eberli D; Donati OF
    Radiology; 2017 Sep; 284(3):725-736. PubMed ID: 28346073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection.
    Westphalen AC; Coakley FV; Roach M; McCulloch CE; Kurhanewicz J
    Radiology; 2010 Aug; 256(2):485-92. PubMed ID: 20551184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers.
    Fütterer JJ; Engelbrecht MR; Huisman HJ; Jager GJ; Hulsbergen-van De Kaa CA; Witjes JA; Barentsz JO
    Radiology; 2005 Nov; 237(2):541-9. PubMed ID: 16244263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact.
    Onay A; Vural M; Armutlu A; Ozel Yıldız S; Kiremit MC; Esen T; Bakır B
    Eur J Radiol; 2019 Mar; 112():192-199. PubMed ID: 30777210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
    Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
    AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.
    Mazaheri Y; Hricak H; Fine SW; Akin O; Shukla-Dave A; Ishill NM; Moskowitz CS; Grater JE; Reuter VE; Zakian KL; Touijer KA; Koutcher JA
    Radiology; 2009 Aug; 252(2):449-57. PubMed ID: 19703883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
    Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
    Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
    Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO
    Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.